Search research articles
Contact Us
Filters
Showing results (581-590 of 594) with videos related to
Page
of 60
Sort By:
RMD Open
|
November 23, 2023
Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus
Hanxiao You, Jiuliang Zhao, Miaojia Zhang, et al.
Rheumatology (Oxford, England)
|
February 3, 2026
Vunakizumab in patients with active psoriatic arthritis: a multicentre, randomized, double-blind, placebo-controlled, phase 2 study
Yu Xue, Lingyun Sun, Ning Zhang, et al.
Arthritis Research & Therapy
|
April 12, 2018
Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study
Yang-Zhong Zhou, Li-Dan Zhao, Hua Chen, et al.
Medcomm
|
February 19, 2025
Low versus high peripheral oxygen saturation directed oxygen therapy in critically ill patients: a multicenter randomized controlled trial
Xiaobo Yang, Xuehui Gao, Xiang Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 2024
The international empirics of management
Daniela Scur, Scott Ohlmacher, John Van Reenen, et al.
The Lancet. Rheumatology
|
January 17, 2024
IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: a randomised, double-blind, phase 3 equivalence trial
Huji Xu, Zhijun Li, Jian Wu, et al.
Eclinicalmedicine
|
May 4, 2026
Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic disease: a multicentre, open-label, randomized, non-inferiority trial
Lifan Zhang, Yujie He, Wenwen Wang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 18, 2013
The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity
Valeriy G Ostapchenko, Flavio H Beraldo, Amro H Mohammad, et al.
JAMA Network Open
|
May 8, 2026
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial
Jian Zhu, Cheng Zhao, Cundong Mi, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
January 1, 2023
An Adhesive Bioink toward Biofabrication under Wet Conditions
Wanlu Li, Mian Wang, Shiwei Wang, et al.
Page
of 60
Search research articles
Search
Showing results (581-590 of 594) with videos related to
Sort By:
Page
of 60
RMD Open
|
November 23, 2023
Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus
Hanxiao You, Jiuliang Zhao, Miaojia Zhang, et al.
Rheumatology (Oxford, England)
|
February 3, 2026
Vunakizumab in patients with active psoriatic arthritis: a multicentre, randomized, double-blind, placebo-controlled, phase 2 study
Yu Xue, Lingyun Sun, Ning Zhang, et al.
Arthritis Research & Therapy
|
April 12, 2018
Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study
Yang-Zhong Zhou, Li-Dan Zhao, Hua Chen, et al.
Medcomm
|
February 19, 2025
Low versus high peripheral oxygen saturation directed oxygen therapy in critically ill patients: a multicenter randomized controlled trial
Xiaobo Yang, Xuehui Gao, Xiang Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 2024
The international empirics of management
Daniela Scur, Scott Ohlmacher, John Van Reenen, et al.
The Lancet. Rheumatology
|
January 17, 2024
IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: a randomised, double-blind, phase 3 equivalence trial
Huji Xu, Zhijun Li, Jian Wu, et al.
Eclinicalmedicine
|
May 4, 2026
Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic disease: a multicentre, open-label, randomized, non-inferiority trial
Lifan Zhang, Yujie He, Wenwen Wang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 18, 2013
The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity
Valeriy G Ostapchenko, Flavio H Beraldo, Amro H Mohammad, et al.
JAMA Network Open
|
May 8, 2026
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial
Jian Zhu, Cheng Zhao, Cundong Mi, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
January 1, 2023
An Adhesive Bioink toward Biofabrication under Wet Conditions
Wanlu Li, Mian Wang, Shiwei Wang, et al.
Page
of 60